Relevant to cancer, growing evidence has demonstrated the potential role of the PAFR signaling in modulating the in vitro and in vivo growth of various tumor types in response to ROS-generating pro-oxidative stressors including therapeutic agents [29,30,31,54,55,56]. Here, PTAFR is linked to cancer.